Randomized phase II evaluation of 6 g/m2 of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (G-CSF) compared with 12 g/m2 of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcoma.
J Clin Oncol
; 23(1): 105-12, 2005 Jan 01.
Article
em En
| MEDLINE
| ID: mdl-15625365
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Sarcoma
/
Neoplasias de Tecidos Moles
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Doxorrubicina
/
Antineoplásicos Alquilantes
/
Ifosfamida
/
Antibióticos Antineoplásicos
Tipo de estudo:
Clinical_trials
/
Prognostic_studies
Limite:
Adolescent
/
Adult
/
Aged
/
Child
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2005
Tipo de documento:
Article